drugset / Trial / NCT02464033
EDCR Study - Etanercept Diamyd Combination Regimen -Open Trial to Evaluate Safety in Children With Type 1 Diabetes
Phase 2
Completed
20 enrolled
Johnny Ludvigsson
Diamyd Medical AB · collabOstergotland County Council, Sweden · collabSwedish Child Diabetes Foundation · collab
NaSingle-groupOpen-labelTreatment
Summary
The objectives of this study is to: * Evaluate the tolerability of a combination therapy with Diamyd, vitamin D and etanercept * Evaluate how the above mentioned treatments influence the immune system and endogenous insulin secretion
Timeline
- Start
- 2015-05
- Primary completion
- 2019-02-25
- Completion
- 2019-02-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etanercept | Protein / enzyme biologic | 0.8 mg/kg | Subcutaneous |
| Subject | GLUTAMATE DECARBOXYLASE 2 | Vaccine | 20 ug | Subcutaneous |
| Subject | Vitamin D | Other / unclassified | 2000 iu | Oral |